GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Targeting an unrecognized checkpoint on T cell function in tumors

$245,776
Robert Langland Eil · Oregon Health & Science University · K08 · FY2024 · CA

Targeting an unrecognized checkpoint on T cell function in tumors

$245,776
Robert Langland Eil · Oregon Health & Science University · K08 · FY2023 · CA

Targeting an unrecognized checkpoint on T cell function in tumors

$245,776
Robert Langland Eil · Oregon Health & Science University · K08 · FY2025 · CA

Targeting an unrecognized checkpoint on T cell function in tumors

$245,776
Robert Langland Eil · Oregon Health & Science University · K08 · FY2022 · CA

3D-Adhesion Stromagenesis in Cancer Permissiveness

$245,775
Edna Cukierman · Research Inst Of Fox Chase Can Ctr · R01 · FY2012 · CA

Hematopoietic Stem Cell-Derived Carcinoma Associated Fibroblasts in Tumor

$245,763
Amanda C. Larue · Medical University Of South Carolina · R01 · FY2013 · CA

Defining a Stromal Signature that Facilitates Progression of Lethal Cancers

$245,738
Philippe D Gascard · University Of California, San Francisco · R50 · FY2019 · CA

A Novel Fluorescence Imaging Platform to Predict Response to Combinatorial Tyrosine Kinase Inhibitors

$245,722
Summer Lynne Gibbs · Oregon Health & Science University · R21 · FY2022 · CA

A Novel High Throughput Tumor Spheroid Microtechnology

$245,707
Hossein Tavana · University Of Akron · R21 · FY2014 · CA

Defining the Hypoxic Immunosuppressive Microenvironment as a Biomarker of Therapy Efficacy in Glioblastoma Using Iron Oxide Enhanced FMISO PET/MRI

$245,663
Ramon Francisco Barajas · Oregon Health & Science University · K08 · FY2023 · CA

Defining the Hypoxic Immunosuppressive Microenvironment as a Biomarker of Therapy Efficacy in Glioblastoma Using Iron Oxide Enhanced FMISO PET/MRI

$245,663
Ramon Francisco Barajas · Oregon Health & Science University · K08 · FY2022 · CA

Defining the Hypoxic Immunosuppressive Microenvironment as a Biomarker of Therapy Efficacy in Glioblastoma Using Iron Oxide Enhanced FMISO PET/MRI

$245,663
Ramon Francisco Barajas · Oregon Health & Science University · K08 · FY2021 · CA

Defining the Hypoxic Immunosuppressive Microenvironment as a Biomarker of Therapy Efficacy in Glioblastoma Using Iron Oxide Enhanced FMISO PET/MRI

$245,663
Ramon Francisco Barajas · Oregon Health & Science University · K08 · FY2020 · CA

Immunoswitch: A novel nanoparticle-based approach to immunotherapy

$245,625
Jonathan P Schneck · Johns Hopkins University · R21 · FY2019 · EB

NeuroVu: A Novel Cloud-based Microscope for Remote Neurosurveillance of the Seizure-Brain Tumor Nexus

$245,625
Danapala M. M. Janaka Senarathna · Johns Hopkins University · R21 · FY2025 · NS

KLH-pulsed dendritic cells plus TNFerade in Pancreatic Cancer

$245,603
Emmanuel E Zervos · East Carolina University · R21 · FY2007 · CA

Project 2: Microenvironment Modification and Anti-PD1 Immunotherapy of Lymphoma

$245,601
George J Weiner · University Of Iowa · P50 · FY2021 · CA

Functional exploration of progenitor renewal and differentiation in oral epithelial homeostasis and cancer

$245,573
Zhe Ying · Icahn School Of Medicine At Mount Sinai · R00 · FY2023 · DE

Core 1: Administrative and Bioinformatics Core

$245,555
Surinder Kumar Batra · University Of Nebraska Medical Center · P01 · FY2019 · CA

Core 2: Animal Model and Experimental Therapeutics Core [AMETC]

$245,554
Maneesh Jain · University Of Nebraska Medical Center · P01 · FY2019 · CA

Multiscale Computational Oncology Research Core

$245,497
Elana Fertig · University Of Tx Md Anderson Can Ctr · U54 · FY2022 · CA

Targeting host immune cells and DAMP molecules to improve outcome in tuberculosis

$245,438
William Ramses Bishai · Johns Hopkins University · R21 · FY2018 · AI

Low-Fat/Fish Oil Diet and prostate Cancer Outcomes in Human Cohorts and Mouse Mo

$245,345
William J Aronson · University Of California Los Angeles · P50 · FY2013 · CA

Host Microenvironment and Bone Metastases

$245,335
Gregory R Mundy · Vanderbilt University · U54 · FY2008 · CA

Interrogating oncogene-dependency and mutation order in FLT3 mutant AML

$245,326
Robert Lyle Bowman · University Of Pennsylvania · R00 · FY2023 · CA